The company
Lifevantage Corporation
LFVN · Nasdaq
We hold no 150-day reading for LFVN yet: it needs about 200 sessions of history. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- not in the set
- Weeks in an uptrend
- —
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $387K
- Insider sales, 12 months
- $613K
- Officials’ trades on record
- 0
- Institutions holding
- 86 (-13)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Darwin LewisDirector | bought | 976at $6.22 | 15 Sep 2026filed 17 Sep 2026 |
| Kristen CunninghamChief Sales Officer | sold | 8,901at $6.18 | 14 Sep 2026filed 14 Sep 2026 |
| Kristen CunninghamChief Sales Officer | sold | 100at $6.41 | 11 Sep 2026filed 14 Sep 2026 |
| Darwin LewisDirector | bought | 705at $8.60 | 15 Jun 2026filed 17 Jun 2026 |
| Michael A. BeindorffDirector | sold | 10,000at $8.55 | 3 Jun 2026filed 5 Jun 2026 |
| Darwin LewisDirector | bought | 1,055at $5.23 | 16 Mar 2026filed 18 Mar 2026 |
| Judd DaytonDirector | bought | 10,500at $4.53 | 2 Mar 2026filed 2 Mar 2026 |
| Judd DaytonDirector | bought | 18,097at $4.63 | 27 Feb 2026filed 2 Mar 2026 |
| Judd DaytonDirector | bought | 4,600at $4.58 | 26 Feb 2026filed 2 Mar 2026 |
| Darwin LewisDirector | bought | 3,955at $5.22 | 9 Feb 2026filed 11 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| CAPITAL MANAGEMENT CORPreduced · filed 29 Jul 2026 | 1,878,411$11.7M | -563,508−23.1% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 669,418$4.2M | -198,286−22.9% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 429,203$2.7M | -219−0.1% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 268,605$1.7M | -501,093−65.1% |
| DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026 | 256,296$1.6M | -19,900−7.2% |
| ENVESTNET ASSET MANAGEMENT INCadded · filed 3 Aug 2026 | 229,907$1.4M | +10,745+4.9% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 2026 | 169,046$1.1M | +169,046 |
| AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026 | 144,386$901K | +39,722+38.0% |
| JANE STREET GROUP, LLCnew · filed 14 Aug 2026 | 138,056$861K | +138,056 |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 120,830$754K | -140,362−53.7% |
News
Everyone who traded it
Same industry
No other stock in its industry this week.
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.